Article
Protective Effect of Carvacrol against Gut Dysbiosis and Clostridium difficile Associated Disease in a Mouse Model
21 Apr 2017
Abstract excerpt
Clostridium difficile is an anaerobic sporeforming pathogen causing a toxin-mediated enteric disease in humans. C. difficile predominantly affects hospital inpatients undergoing prolonged antibiotic therapy, which results in enteric dysbiosis, leading to C. difficile spore germination, pathogen colonization in the intestine and subsequent toxin production. Therapeutic agents that inhibit C. difficile without...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
